chr4-53507446-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001126328.3(LNX1):āc.646A>Gā(p.Ile216Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000706 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001126328.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LNX1 | NM_001126328.3 | c.646A>G | p.Ile216Val | missense_variant | 4/11 | ENST00000263925.8 | |
LNX1-AS1 | NR_046622.1 | n.266+5470T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LNX1 | ENST00000263925.8 | c.646A>G | p.Ile216Val | missense_variant | 4/11 | 1 | NM_001126328.3 | P1 | |
LNX1-AS1 | ENST00000511989.5 | n.113+5470T>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251284Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135816
GnomAD4 exome AF: 0.0000711 AC: 104AN: 1461804Hom.: 0 Cov.: 32 AF XY: 0.0000729 AC XY: 53AN XY: 727200
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.646A>G (p.I216V) alteration is located in exon 4 (coding exon 3) of the LNX1 gene. This alteration results from a A to G substitution at nucleotide position 646, causing the isoleucine (I) at amino acid position 216 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at